Riskpilot← Back to searchSign inGet full accessBIOCENTECH APS
APSActiveCVR 25437470Fruebjergvej 3Manufacture of other special-purpose machinery n.e.c. · NACE 2899Est. 2000— employees
Revenue 2024
DKK -18K
+20% vs 2023
EBITDA margin
100.0%
-20% vs 2023
Equity ratio
-62.2%
Financial strength
Net profit 2024
DKK -19K
-18% vs 2023
| Revenue | DKK -18K | +20% |
| EBITDA | DKK -18K | -20% |
| Net profit | DKK -19K | -18% |
| Total assets | DKK 75K | -3% |
| Equity | DKK -47K | -71% |
| Employees | — | — |
Legal name
BIOCENTECH APS
CVR number
25437470
Legal form
Anpartsselskab
NACE code
2899 · Manufacture of other special-purpose machinery n.e.c.
Founded
1. maj 2000
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af selskabets direktør
Company purpose
Selskabets formål er udvikling og salg af miljøteknologi.
Address
Fruebjergvej 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 95 | -10 | -6 | -4 | -4 | -4 | -8 | -5 | -6 | -6 | -5 | -13 | -15 | -18 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 95 | -10 | -6 | -4 | -4 | -4 | -8 | -5 | -6 | -6 | -5 | -13 | -15 | -18 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 95 | -10 | -6 | -4 | -4 | -4 | -8 | -5 | -6 | -6 | -5 | -13 | -15 | -18 |
| Net financials | -4 | 4 | 1 | 2 | 2 | 1 | 1 | 0 | -0 | -1 | -1 | -0 | -2 | -2 |
| Profit before tax | 91 | -6 | -4 | -3 | -3 | -3 | -7 | -5 | -7 | -7 | -6 | -14 | -16 | -19 |
| Tax | -4 | -1 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | 95 | -4 | -3 | -2 | -3 | -3 | -7 | -5 | -7 | -7 | -6 | -14 | -16 | -19 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 68 | 65 | 68 | 68 | 70 | 72 | 74 | 76 | 77 | 80 | 79 | 79 | 77 | 75 |
| Equity | 51 | 46 | 43 | 41 | 38 | 35 | 28 | 24 | 17 | 9 | 3 | -11 | -27 | -47 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 17 | 19 | 25 | 27 | 32 | 37 | 46 | 52 | 61 | 71 | 76 | 90 | 105 | 122 |
| Total debt | 17 | 19 | 25 | 27 | 32 | 37 | 46 | 52 | 61 | 71 | 76 | 90 | 105 | 122 |
EBITDA margin
-1769000.0%
This company
15.8%
Market median
-11196303% vs market
20122024
Equity ratio
-62.2%
This company
38.2%
Market median
-263% vs market
20122024
Return on equity
-1936300.0%
This company
18.4%
Market median
-10523470% vs market
20122024
Net profit margin
-1936300.0%
This company
8.1%
Market median
-23905038% vs market
20122024
Asset turnover
-0.24×
This company
1.12×
Market median
-121% vs market
20122024
Debt / equity
2.61×
This company
0.62×
Market median
-321% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-10-01 – 2022-12-31
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AN Management | Management | 2004 | — | — |
MG Management | Management | 2000 | — | — |
EJ Founder | Founder | 2000 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
NÆRVIG GROUP ApS | Company | 100.0% | 100.0% | 2000 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NÆRVIG GROUP ApS
BIOCENTECH APS Board members of BIOCENTECH APS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Aleksander Nærvig | Management | 0 companies |
| Martin Garbrecht Damm | Management | 0 companies |
| Erik Jensen | Founder | 0 companies |